Skip to main content
Skip to content
Case File
efta-efta01939674DOJ Data Set 10Correspondence

EFTA Document EFTA01939674

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01939674
Pages
0
Persons
0
Integrity
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
To: Jeffrey epstein aeevacation@gmail.com)fjeffrey epstein (jeevacation6gmail.com)J: jeevacationegmail.comUeevacation©gmail.comi From: Boris Nikolic Sent Wed 2/5/2014 8:26:02 PM Subject: FW: Bio Larry checked with all teams and I got approval for what I did — below. There is also part of my previous Harvard life that I cut down significantly. Finishing other parts as well. B From: Larry Cohen Sent: Wednesday, February 5, 2014 11:17 AM To: Boris Nikolic Subject: Bio Bill and Julie have approved this (below) Good? Most recently, Dr. Boris Nikolic served as Chief Advisor for Science and Technology to Bill Gates at bgC3 (the private office of Bill Gates) and at the Bill & Melinda Gates Foundation (BMGF). Boris is now focused full time on the DST healthcare fund. Nikolic led select for-profit and not-for-profit investment activities at these Gates-affiliated organizations. EFTA_R1_00397422 EFTA01939674 On the for-profit side, Nikolic led investments in various life science/health care companies such as Foundation Medicine, Research Gate, Schrodinger and Nimbus. On the not-for profit side, Boris co-managed BMGF's $1.5 billion strategic investment pool focused on program-related investments in global health, as well as in other program areas (agriculture, digital payments and US education). Boris focused on biotech investments specifically, and pioneered direct equity investments by a US foundation in companies with platform technologies applicable to global health. BMGF's biotech portfolio includes five biotech companies: Liquidia, Genocea, Visterra, Atreca and Anacor. At BMGF, Boris also led discovery program of novel diagnostics platform technologies, molecular diagnostics point-of-care applications, novel immunological detection systems, vaccination and surveillance technologies. EFTA_R1_00397423 EFTA01939675

Technical Artifacts (2)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

Domainjeevacation6gmail.com
Emailaeevacation@gmail.com

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.